9114 related articles for article (PubMed ID: 1490113)
1. Local control of subcutaneous murine melanoma xenografts in nude mice by neutron capture therapy.
Allen BJ; Corderoy-Buck S; Mallesch JL; Crotty K; Moore DE
Melanoma Res; 1992 Nov; 2(4):253-62. PubMed ID: 1490113
[TBL] [Abstract][Full Text] [Related]
2. Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
Coderre JA; Glass JD; Packer S; Micca P; Greenberg D
Pigment Cell Res; 1990 Dec; 3(6):310-8. PubMed ID: 2101931
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
4. Use of nude mice in experimental neutron capture therapy with 10B-BPA.
Tamaoki N; Ueda M; Tamauchi S; Yamamoto K; Mishima Y
Pigment Cell Res; 1989; 2(4):343-4. PubMed ID: 2798327
[TBL] [Abstract][Full Text] [Related]
5. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
[TBL] [Abstract][Full Text] [Related]
6. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
Coderre JA; Slatkin DN; Micca PL; Ciallella JR
Radiat Res; 1991 Nov; 128(2):177-85. PubMed ID: 1947013
[TBL] [Abstract][Full Text] [Related]
8. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; FarÃas S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
9. Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation.
Ichihashi M; Nakanishi T; Mishima Y
J Invest Dermatol; 1982 Mar; 78(3):215-8. PubMed ID: 7057053
[TBL] [Abstract][Full Text] [Related]
10. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of a murine melanoma.
Coderre JA; Kalef-Ezra JA; Fairchild RG; Micca PL; Reinstein LE; Glass JD
Cancer Res; 1988 Nov; 48(22):6313-6. PubMed ID: 3180048
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.
Fukuda H; Hiratsuka J; Honda C; Kobayashi T; Yoshino K; Karashima H; Takahashi J; Abe Y; Kanda K; Ichihashi M
Radiat Res; 1994 Jun; 138(3):435-42. PubMed ID: 8184019
[TBL] [Abstract][Full Text] [Related]
13. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
[TBL] [Abstract][Full Text] [Related]
15. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
[TBL] [Abstract][Full Text] [Related]
16. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
17. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.
Coderre JA; Glass JD; Fairchild RG; Micca PL; Fand I; Joel DD
Cancer Res; 1990 Jan; 50(1):138-41. PubMed ID: 2293547
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
[TBL] [Abstract][Full Text] [Related]
19. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
20. Selective boron accumulation in human ocular melanoma vs surrounding eye components after 10B1-p-boronophenylalanine administration. Prerequisite for clinical trial of neutron-capture therapy.
Wadabayashi N; Honda C; Mishima Y; Ichihashi M
Melanoma Res; 1994 Jun; 4(3):185-90. PubMed ID: 7919964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
